Epidemiological Study and Clinical Profile of Parkinson's Disease in the Assiut Governorate, Egypt: a Community-based Study
Overview
Public Health
Authors
Affiliations
Background: Few comprehensive epidemiological studies of the prevalence of Parkinson's disease (PD) have been undertaken in Arab countries, and none has been carried out in Egypt. A community-based survey was conducted in the Assiut Governorate to estimate the prevalence and clinical profile of PD.
Methods: A community-based study was carried out, with random sampling of 7 districts, involving 6,498 inhabitants. Out of this sample, 578 subjects dropped out, leaving 3,066 males (51.8%) and 2,854 females (48.2%). There were 3,660 urban residents (61.8%) and 2,260 (38.2%) from the rural community. Patients were evaluated using a screening questionnaire, the Unified Parkinson Disease Rating Scale and the Non-Motor Symptoms Scale for PD.
Results: Thirty-nine subjects were found to have parkinsonism, giving a crude prevalence rate of 659/100,000 inhabitants. Of these subjects, 33 were diagnosed with PD (21 males), with a mean age of 66.9 ± 8.4 years, a crude prevalence rate of 557/100,000 and an age-specific prevalence rate (≥50 years old) of 2,748/100,000. There were more males than females (3,395 vs. 1,989/100,000), but the difference was not significant. The highest age-specific prevalence rate was recorded among subjects 70-79 years old (7,263/100,000). There was a significantly higher prevalence among rural than urban inhabitants (973 vs. 301/100,000) and among illiterate than literate persons (1,103 vs. 280/100,000). The clinical profile of our patients was similar to that of other populations but was characterized by a high prevalence of mood/cognition dysfunction and gastrointestinal symptoms; there were few reported perceptual problems.
Conclusion: The overall prevalence of PD was high, especially in older adults.
Neuropsychiatric symptoms in Parkinson's disease: review of data from the Arab world.
Chabbouh A, Khalil H, Abboud C, Sader A, Khoury R J Int Med Res. 2024; 52(12):3000605241304646.
PMID: 39687936 PMC: 11653321. DOI: 10.1177/03000605241304646.
William M, Hamed S, Shalash A, Khedr E, Yousef M, El-Jaafary S NPJ Parkinsons Dis. 2024; 10(1):215.
PMID: 39505921 PMC: 11541850. DOI: 10.1038/s41531-024-00826-8.
Pereira G, Teixeira-Dos-Santos D, Soares N, Marconi G, Friedrich D, Saffie Awad P NPJ Parkinsons Dis. 2024; 10(1):181.
PMID: 39349513 PMC: 11442769. DOI: 10.1038/s41531-024-00779-y.
Khedr E, Ahmed G, Korayem M, Elamary S, El-Kholy M, Haridy N Brain Sci. 2024; 14(6).
PMID: 38928556 PMC: 11201640. DOI: 10.3390/brainsci14060556.
van Wamelen D, Sauerbier A, Leta V, Rodriguez-Blazquez C, Falup-Pecurariu C, Rodriguez-Violante M Sci Rep. 2021; 11(1):9611.
PMID: 33953218 PMC: 8100281. DOI: 10.1038/s41598-021-88651-4.